FDA Clears Transit Scientific’s XO Angioplasty Platform

The FDA has cleared Transit Scientific’s XO RX 2.2F and XO RX 3.8F angioplasty devices for treating narrowing of peripheral arteries and lesions associated with arteriovenous dialysis fistulas.

The devices use rotating strut technology to break and dilate calcium. The 3.8 model can accommodate 20 cm balloons, making it a good option for peripheral artery disease and critical limb ischemia, the company said.

The lower profile 2F version is also an option for treating patients with below-the-knee, tibiopedal and pedal loop stenoses.

The XO technology is compatible with hundreds of angioplasty balloons, the Salt Lake City, Utah-based company said.